Evidence map›Paper›PMID 16849905›Full record

ReviewJournal of clinical hypertension (Greenwich, Conn.)2006

Serum uric acid as a risk factor for cardiovascular and renal disease: an old controversy revived.

Francesca Viazzi, Giovanna Leoncini, Elena Ratto, Roberto Pontremoli

Open access · greenAbstract readReview
In one paragraph

Review in Journal of clinical hypertension (Greenwich, Conn.), 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 43 citations in OpenAlex.

  1. The effects of topiroxostat on vascular function in patients with hyperuricemia.Journal of clinical hypertension (Greenwich, Conn.) · 2019
    Article
  2. Article
  3. Article
  4. Vascular Aging and Disease of the Large Vessels: Role of Inflammation.High blood pressure & cardiovascular prevention : the official journal of the Italian Society of Hypertension · 2019
    Review
  5. Review
  6. Sex-related relationships between uric acid and target organ damage in hypertension.Journal of clinical hypertension (Greenwich, Conn.) · 2018
    Article
  7. Article
  8. Serum uric acid still carries controversies about its role in endothelial dysfunction.Journal of clinical hypertension (Greenwich, Conn.) · 2013
    Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Francesca ViazziDepartment of Internal Medicine, University of Genoa, Genoa, Italy. francesca.viazzi@unige.it
Giovanna Leoncini
Elena Ratto
Roberto Pontremoli
Ospedale Policlinico San Martino · ITUniversity of Genoa · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperuricemia is commonly associated with traditional risk factors such as abnormalities in glucose metabolism, dyslipidemia, and hypertension. Recent studies have revived the controversy over the role of serum uric acid as an independent prognostic factor for cardiovascular mortality. The authors review clinical and experimental evidence concerning the role of serum uric acid in the development of cardiovascular and renal damage. Results of trials suggesting that serum uric acid variations over time may have a prognostic impact are also discussed.

Indexed as

Cardiovascular DiseasesClinical Trials as TopicHumansHyperuricemiaKidney DiseasesRisk FactorsUric AcidUric Acid

Identifiers

PMID16849905
PMCPMC8109461
OpenAlexW2045656367

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.